Healthegy

Medtech Talk

Business EN ↓ Епізодів: 206

A weekly conversation with the innovators who will change how health care is delivered.

Автор

Healthegy

Категорія

Business

Сайт подкасту

healthegy.com

Останній епізод

19 тра 2026

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Встановіть безкоштовно Android майже 10 млн завантажень · рейтинг 4,8 iOS незабаром

Епізоди

Foundry’s Gifford: Innovating Innovation in a Changing Health Care World 23.04.2015 27:28

Hanson Gifford of The Foundry reviews the evolving challenges behind Medtech innovation and shares details on Fire1 and Ardian.

Ascension’s Hermann Talks State of Payer Provider Venture Groups 13.04.2015 18:01

Matt Hermann, Senior Managing Director of Ascension Ventures, details how Pro-viders and Payer-sponsored investment firms have grown into influential investors in health care.

Vivo Capital Building Bridges Across Pacific 09.04.2015 20:09

Vivo Capital, fresh off raising $750 million for its eight fund, has effectively strad-dled the Pacific, investing in life sciences in US and China. Managing Partner Chen Yu, MD, shares Vivo’s story and explains how US Medtech start-ups stand to benefit from China’s soar-ing health care sector.

Holaira’s Wahr Sees Success Ahead for Medtech 26.03.2015 23:08

Dennis Wahr, MD, CEO of Holaira Inc. and co-chair of the Medtech In-vesting Conference, says “the best is yet to come” for Medtech and shares his strategy for successful VC fund raising.

NEA’s Klein Sees Opportunities in Medtech 26.03.2015 26:19

Justin Klein, MD, general partner at NEA and co-chair of the Medtech Investing Conference, presented NEA’s views the best opportunities in Medtech.

Intersect ENT Keeps Pace in Tech Rich Silicon Valley 18.03.2015 20:00

Intersect ENT CEO Lisa Earnhardt shares her perspective of ENT, the entire Medtech sector and how Intersect is outpacing its tech partners in one critical metric.